BlackRock Fund Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.84B Buy
15,858,169
+283,004
+2% +$31.5M 0.34% 39
2016
Q3
$1.63B Buy
15,575,165
+508,334
+3% +$55M 0.33% 41
2016
Q2
$1.49B Buy
15,066,831
+48,168
+0.3% +$4.98M 0.33% 45
2016
Q1
$1.5B Sell
15,018,663
-1,060,431
-7% -$109M 0.35% 40
2015
Q4
$1.93B Buy
16,079,094
+219,111
+1% +$25.3M 0.44% 34
2015
Q3
$1.72B Buy
15,859,983
+126,804
+0.8% +$15.7M 0.44% 29
2015
Q2
$1.82B Buy
15,733,179
+708,365
+5% +$81M 0.44% 29
2015
Q1
$1.73B Buy
15,024,814
+1,169,746
+8% +$140M 0.41% 28
2014
Q4
$1.55B Buy
13,855,068
+712,332
+5% +$75.1M 0.38% 33
2014
Q3
$1.25B Sell
13,142,736
-85,154
-0.6% -$7.68M 0.35% 36
2014
Q2
$1.14B Sell
13,227,890
-817,624
-6% -$62.2M 0.32% 37
2014
Q1
$980M Buy
14,045,514
+1,587,688
+13% +$126M 0.29% 43
2013
Q4
$1.05B Buy
12,457,826
+233,506
+2% +$18.5M 0.32% 38
2013
Q3
$942M Buy
12,224,320
+454,472
+4% +$31.8M 0.32% 39
2013
Q2
$688M Buy
+11,769,848
New +$708M 0.25% 48

Other funds holding CELG

BlackRock Fund Advisors's CELG Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Celgene Corp (CELG) stake by 1.8% in Q4 2016, buying an estimated $31.5M and bringing the position to 15,858,169 shares worth $1.84B. The position accounts for 0.34% of the portfolio, ranked #39.

BlackRock Fund Advisors first reported a position in CELG in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.93B in Q4 2015. 1,375 funds tracked by Wall St. Rank hold CELG as of Q4 2016.

  • BlackRock Fund Advisors held 15,858,169 shares of Celgene Corp worth $1.84B as of Q4 2016.
  • BlackRock Fund Advisors bought 283,004 Celgene Corp shares in Q4 2016, an estimated $31.5M.
  • Celgene Corp made up 0.34% of BlackRock Fund Advisors's portfolio in Q4 2016, its #39 holding.
  • BlackRock Fund Advisors first reported a position in Celgene Corp in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Celgene Corp position peaked at $1.93B in Q4 2015.
  • 1,375 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.